Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-23-000336
Filing Date
2023-07-10
Accepted
2023-07-10 16:29:38
Documents
41
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 abti10k033123.htm   iXBRL 10-K 960106
2 GRAPHIC image_004.jpg GRAPHIC 2736
3 GRAPHIC image_002.jpg GRAPHIC 3960
4 GRAPHIC image_005.jpg GRAPHIC 11303
10 ex31_1.htm EX-31.1 9046
11 ex31_2.htm EX-31.2 9047
12 ex32_1.htm EX-32.1 5769
  Complete submission text file 0001663577-23-000336.txt   2921642

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abti-20230331.xsd EX-101.SCH 17664
6 XBRL CALCULATION FILE abti-20230331_cal.xml EX-101.CAL 31716
7 XBRL DEFINITION FILE abti-20230331_def.xml EX-101.DEF 49314
8 XBRL LABEL FILE abti-20230331_lab.xml EX-101.LAB 158306
9 XBRL PRESENTATION FILE abti-20230331_pre.xml EX-101.PRE 127204
35 EXTRACTED XBRL INSTANCE DOCUMENT abti10k033123_htm.xml XML 200013
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-156091 | Film No.: 231080020
SIC: 2833 Medicinal Chemicals & Botanical Products